Efficacy and circulating tumor DNA (ctDNA) analysis of the BRAF inhibitor dabrafenib (D), MEK inhibitor trametinib (T), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E-mutated (BRAFm) metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Corcoran, R. B.; Andre, T.; Yoshino, T.; Bendell, J. C.; Atreya, C. E.; Schellens, J. H. M.; Ducreux, M. P.; McRee, A.; Siena, S.; Middleton, G.; Gordon, M.; Humblet, Y.; Muro, K.; Elez, E.; Yaeger, R.; Sidhu, R.; Squires, M.; Jaeger, S.; Rangwala, F.; Van Cutsem, E. |
| Abstract Title: | Efficacy and circulating tumor DNA (ctDNA) analysis of the BRAF inhibitor dabrafenib (D), MEK inhibitor trametinib (T), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E-mutated (BRAFm) metastatic colorectal cancer (mCRC) |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi150 |
| Language: | English |
| ACCESSION: | WOS:000393912500453 |
| DOI: | 10.1093/annonc/mdw370.04 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 455O -- Source: Wos |
